{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-23-164486","form_type":"8-K","ticker":"SLDB","cik":"0001707502","company_name":"Solid Biosciences Inc.","filed_at":"2023-06-09T23:59:59+00:00","discovered_at":"2026-05-14T18:03:40.139634+00:00","generated_at":"2026-06-14T04:03:47.725127+00:00","sec_items":["5.02","5.07","9.01"],"event_type":"other","sentiment":"neutral","materiality_score":0.2,"calibrated_materiality_score":0.2,"confidence":"high","headline":"Solid Biosciences stockholders elect four Class II directors, ratify auditor, approve ESPP amendment","bullets":["Elected Clare Kahn, Adam Koppel, Adam Stone, Lynne Sullivan as Class II directors to 2026; votes ranged 13.6M–14.2M for, 76K–664K withheld.","Ratified PricewaterhouseCoopers LLP as auditor for FY 2023 with 15.3M for, 4.9K against, 5.5K abstain.","Approved amendment to 2021 ESPP increasing shares available for issuance; 13.6M for, 679K against, 4K abstain.","All results from June 6, 2023 Annual Meeting; broker non-votes of ~1.1M on director election and ESPP amendment."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-23-164486","json":"https://secwatch.observer/filing/0001193125-23-164486.json","markdown":"https://secwatch.observer/filing/0001193125-23-164486.md","text":"https://secwatch.observer/filing/0001193125-23-164486.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1707502/000119312523164486/0001193125-23-164486-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1707502/000119312523164486/d513689d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-14T04:03:47.725127+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"1c209f0ca996cb7336872611c9eaed8255c57f11","claim":"Solid Biosciences Inc. shareholders approved Election of Class II directors at the 2023-06-06 meeting.","evidence_excerpt":"The Company held its Annual Meeting on June 6, 2023 to consider and vote upon the matters listed below.","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/1707502/000119312523164486/0001193125-23-164486-index.htm","confidence":0.9,"family_label":"Shareholder Votes","details":[{"label":"Proposal","value":"director election"},{"label":"Outcome","value":"passed"},{"label":"Meeting","value":"2023-06-06"}],"fact_type":"shareholder_vote"},{"claim_id":"9605abb12c57ac3192ff090a3d52977fd85169f9","claim":"Solid Biosciences Inc. shareholders approved Amendment to the Company's 2021 Employee Stock Purchase Plan to increase number of shares available for issuance at the 2023-06-06 meeting.","evidence_excerpt":"The Company’s stockholders approved an amendment to the Company’s 2021 Employee Stock Purchase Plan to increase the number of shares available for issuance thereunder.","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/1707502/000119312523164486/0001193125-23-164486-index.htm","confidence":0.9,"family_label":"Shareholder Votes","details":[{"label":"Proposal","value":"equity plan"},{"label":"Outcome","value":"passed"},{"label":"Meeting","value":"2023-06-06"}],"fact_type":"shareholder_vote"},{"claim_id":"a00d0ff0b9d06976fabba66dfdf5556f3c85dcd2","claim":"Solid Biosciences Inc. shareholders approved Ratification of appointment of PricewaterhouseCoopers LLP as independent registered public accounting firm for fiscal year ending December 31, 2023 at the 2023-06-06 meeting.","evidence_excerpt":"The Company’s stockholders ratified the appointment of PricewaterhouseCoopers LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2023.","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/1707502/000119312523164486/0001193125-23-164486-index.htm","confidence":0.9,"family_label":"Shareholder Votes","details":[{"label":"Proposal","value":"auditor ratification"},{"label":"Outcome","value":"passed"},{"label":"Meeting","value":"2023-06-06"}],"fact_type":"shareholder_vote"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}